Comparable stake leader
Empery Asset Management, LP
SEC ownership of NERVGEN PHARMA CORP.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001751912.
Disclosed value leader
Empery Asset Management, LP
Comparable rows
0/50
Latest evidence
30 Jun 2026
- Public ticker
- NGEN on Nasdaq
- Parsed ownership sources
-
13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Empery Asset Management, LP
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001751912
- Issuer location
- Vancouver, British Columbia, Canada
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of NERVGEN PHARMA CORP. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Empery Asset Management, LP
Disclosed value leader
Empery Asset Management, LP
Comparable rows
0/50
Latest evidence
30 Jun 2026
13F
Highest disclosed value: $8,240,000
50 rows are not safely comparable across share classes.
Showing 1-8 of 50 holder rows.
Quick read
Empery Asset Management, LP has the largest disclosed position value at $8.24M.
0 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Empery Asset Management, LP's linked filing trail.
Disclosed position value
Top 5
Empery Asset Management, LP
$8.24M
Rock Springs Capital Management LP
$2.49M
DAFNA Capital Management LLC
$2.16M
Ghisallo Capital Management LLC
$2.06M
ARMISTICE CAPITAL, LLC
$1.4M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Empery Asset Management, LP |
13F
Company
|
—
class O/S missing
|
$8,240,000
4,000,000 shares
|
— | 30 Jun 2026 |
| Rock Springs Capital Management LP |
13F
Company
|
—
class O/S missing
|
$2,488,956
1,208,231 shares
|
— | 30 Jun 2026 |
| DAFNA Capital Management LLC |
13F
Company
|
—
class O/S missing
|
$2,163,000
1,050,000 shares
|
— | 30 Jun 2026 |
| Ghisallo Capital Management LLC |
13F
Company
|
—
class O/S missing
|
$2,060,000
1,000,000 shares
|
— | 30 Jun 2026 |
| ARMISTICE CAPITAL, LLC |
13F
Company
|
—
class O/S missing
|
$1,396,680
678,000 shares
|
— | 30 Jun 2026 |
| LMR Partners LLP |
13F
Company
|
—
class O/S missing
|
$1,236,000
600,000 shares
|
— | 30 Jun 2026 |
| MARSHALL WACE, LLP |
13F
Company
|
—
class O/S missing
|
$898,081
435,962 shares
|
— | 30 Jun 2026 |
| UBS Group AG |
13F
Company
|
—
class O/S missing
|
$782,236
379,726 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 17 Sep 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Recent insider transactions for NERVGEN PHARMA CORP.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.